Freezing of Fresh Wharton's Jelly from Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies

Journal of Cellular Biochemistry

Volumn 117, Issue 4, 2016, Pages 815-827

  Fong, Chui Yee ^a   Subramanian, Arjunan ^a   Biswas, Arijit ^a   Bongso, Ariff ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CHARACTERIZATION; CRYOPRESERVATION; FREEZE THAW CELL SURVIVAL RATES; HUMAN UMBILICAL CORD; MIXED CORD; WHARTON'S JELLY; WHARTON'S JELLY STEM CELLS

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 2; FATTY ACID BINDING PROTEIN 4; FIBROMODULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BAX; PROTEIN P21; PROTEIN P53; BAX PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; BIOLOGICAL MARKER; BIRC5 PROTEIN, HUMAN; CRYOPROTECTIVE AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; INHIBITOR OF APOPTOSIS PROTEIN; LEUKOCYTE ANTIGEN; LIPOCORTIN 5; PROTEIN BCL 2; RHO KINASE; ROCK1 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURVIVAL; CELL THERAPY; CELL VIABILITY; FREEZE THAWING; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MARKER GENE; MESENCHYMAL STEM CELL; PRIMARY CULTURE; PRIORITY JOURNAL; REGULATOR GENE; UMBILICAL CORD BLOOD; WHARTON JELLY; CELL COUNT; CELL SEPARATION; CHONDROCYTE; CRYOPRESERVATION; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; FIBROBLAST; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOBLAST; PRIMARY CELL CULTURE; PROCEDURES; TISSUE CULTURE TECHNIQUE; UMBILICAL CORD;

ANNEXIN A5; ANTIGENS, CD; BCL-2-ASSOCIATED X PROTEIN; BIOMARKERS; CELL COUNT; CELL DIFFERENTIATION; CELL SEPARATION; CELL SURVIVAL; CHONDROCYTES; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPITHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-BCL-2; RHO-ASSOCIATED KINASES; TISSUE CULTURE TECHNIQUES; TUMOR SUPPRESSOR PROTEIN P53; UMBILICAL CORD; WHARTON JELLY;

EID: 84958125748     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25375     Document Type: Article

References (56)

1. Armitage WJ, Juss BK, Easty DL,. 1994. Response of epithelial (MDCK) cell junctions to calcium removal and osmotic stress is influenced by temperature. Cryobiology 31: 453-460.
2. Balci D, Can A,. 2013. The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking. Curr Stem Cell Res Ther 8: 60-72.
3. Bara JJ, Richards RG, Alini M, Stoddart MJ,. 2014. Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: Implications for basic research and the clinic. Stem Cells 32: 1713-1723.
4. Ben-David U, Benvenisty N,. 2011. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11: 268-277.
5. Ben-David U, Mayshar Y, Benvenisty N,. 2011. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 9: 97-102.
6. Bischof J, Christov K, Rubinsky B,. 1993. A morphological study of cooling rate response in normal and neoplastic human liver tissue: Cryosurgical implications. Cryobiology 30: 482-492.
7. Bongso A, Fong CY,. 2013. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord. Stem Cell Rev 9: 226-240.
8. Bosch J, Houben AP, Radke TF, Stapelkamp D, Bunemann E, Balan P, Buchheiser A, Liedtke S, Kogler G,. 2012. Distinct differentiation potential of "MSC" derived from cord blood and umbilical cord: Are cord-derived cells true mesenchymal stromal cells? Stem Cells Dev 21: 1977-1988.
9. Bueno C, Montes R, Menendez P,. 2010. The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs. Stem Cell Rev 6: 215-223.
10. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM,. 2001. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98: 2396-2402.
11. Capelli C, Gotti E, Morigi M, Rota C, Weng L, Dazzi F, Spinelli O, Cazzaniga G, Trezzi R, Gianatti A, Rambaldi A, Golay J, Introna M,. 2011. Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy 13: 786-801.
12. Carpenter JF, Dawson PE,. 1991. Quantitation of dimethyl sulfoxide in solutions and tissues by high-performance liquid chromatography. Cryobiology 28: 210-215.
13. Chatzistamatiou TK, Papassavas AC, Michalopoulos E, Gamaloutsos C, Mallis P, Gontika I, Panagouli E, Koussoulakos SL, Stavropoulos-Giokas C,. 2014. Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: An MSC banking protocol validation for the Hellenic Cord Blood Bank. Transfusion 54: 3108-3120.
14. Conconi MT, Liddo RD, Tommasini M, Calore C, Parnigotto PP,. 2011. Phenotype and differentiation potential of stromal populations obtained from various zones of human umbilical cord: An overview. Open Tissue Eng Regen Med J 4: 6-20.
15. Dhanasekaran DN, Reddy EP,. 2008. JNK signaling in apoptosis. Oncogene 27: 6245-6251.
16. Diaz-Prado S, Muinos-Lopez E, Hermida-Gomez T, Rendal-Vazquez ME, Fuentes-Boquete I, de Toro FJ, Blanco FJ,. 2011. Isolation and characterization of mesenchymal stem cells from human amniotic membrane. Tissue Eng Part C Methods 17: 49
17. Diller KR,. 1992. Modeling of bioheat transfer processes at high and low temperatures. Adv Heat Transfer 22: 157-357.
18. Djuwantono T, Wirakusumah FF, Achmad TH, Sandra F, Halim D, Faried A,. 2011. A comparison of cryopreservation methods: Slow-cooling vs. rapid-cooling based on cell viability, oxidative stress, apoptosis, and CD34+ enumeration of human umbilical cord blood mononucleated cells. BMC Res Notes 4: 371.
19. Farias VA, Linares-Fernandez JL, Penalver JL, Paya Colmenero JA, Ferron GO, Duran EL, Fernandez RM, Olivares EG, O'Valle F, Puertas A, Oliver FJ, Ruiz de Almodovar JM,. 2011. Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta 32: 86-95.
20. Fong CY, Richards M, Manasi N, Biswas A, Bongso A,. 2007. Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online 15: 708-718.
21. Fong CY, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande MP, Bongso A,. 2010. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties, and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online 21: 391-401.
22. Gauthaman K, Richards M, Wong J, Bongso A,. 2007. Comparative evaluation of the effects of statins on human stem and cancer cells in vitro. Reprod Biomed Online 15: 566-581.
23. Gauthaman K, Fong CY, Subramanian A, Biswas A, Bongso A,. 2010. ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation. Stem Cell Rev 6: 665-676.
24. Gong W, Han Z, Zhao H, Wang Y, Wang J, Zhong J, Wang B, Wang S, Wang Y, Sun L, Han Z,. 2012. Banking human umbilical cord-derived mesenchymal stromal cells for clinical use. Cell Transplant 21: 207-216.
25. Gonzalez R, Griparic L, Umana M, Burgee K, Vargas V, Nasrallah R, Silva F, Patel A,. 2010. An efficient approach to isolation and characterization of pre- and postnatal umbilical cord lining stem cells for clinical applications. Cell Transplant 19: 1439-1449.
26. Hendijani F, Sadeghi-Aliabadi H, Haghjooy Javanmard S,. 2014. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix. Cell Tissue Bank 15: 555-565
27. Hu J, Yu X, Wang Z, Wang F, Wang L, Gao H, Chen Y, Zhao W, Jia Z, Yan S, Wang Y,. 2013. Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J 60: 347-357.
28. IIlancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U,. 2007. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77: 577-588.
29. Jung KH, Yi T, Son MK, Song SU, Hong SS,. 2015. Therapeutic effect of human clonal bone marrow-derived mesenchymal stem cells in severe acute pancreatitis. Arch Pharm Res 38: 742-751
30. Karlsson JO, Toner M,. 1996. Long-term storage of tissues by cryopreservation: Critical issues. Biomaterials 17: 243-256.
31. Kita K, Gauglitz GG, Phan TT, Herndon DN, Jeschke MG,. 2010. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev 19: 491-502.
32. Larese A, Yang H, Petrenko A, McGann L,. 1992. Intracellular ice formation is affected by cell-to-cell contact. Cryobiology 29: 728.
33. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH,. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675.
34. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC,. 2006. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91: 1017-1026.
35. Lv YT, Zhang Y, Liu M, Qiuwaxi JN, Ashwood P, Cho SC, Huan Y, Ge RC, Chen XW, Wang ZJ, Kim BJ, Hu X,. 2013. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med 11: 196.
36. Majore I, Moretti P, Stahl F, Hass R, Kasper C,. 2011. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev 7: 17-31.
37. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F,. 2001. Isolation of human mesenchymal stem cells: Bone marrow versus umbilical cord blood. Haematologica 86: 1099-1100.
38. Mihu CM, Rus Ciuca D, Soritau O, Susman S, Mihu D,. 2009. Isolation and characterization of mesenchymal stem cells from the amniotic membrane. Rom J Morphol Embryol 50: 73-77.
39. Musina RA, Bekchanova ES, Belyavskii AV, Grinenko TS, Sukhikh GT,. 2007. Umbilical cord blood mesenchymal stem cells. Bull Exp Biol Med 143: 127-131.
40. Pereira WC, Khushnooma I, Madkaikar M, Ghosh K,. 2008. Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. J Tissue Eng Regen Med 2: 394-399.
41. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
42. Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q, Jiang R, Yan Y, Mao F, Yang H, Wang X, Chen Y,. 2008. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 32: 8-15.
43. Reza HM, Ng BY, Phan TT, Tan DT, Beuerman RW, Ang LP,. 2011. Characterization of a novel umbilical cord lining cell with CD227 positivity and unique pattern of P63 expression and function. Stem Cell Rev 7: 624-638.
44. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE,. 2005. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23: 220-229.
45. Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE,. 2009. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS ONE 4: e6498.
46. Secco M, Moreira YB, Zucconi E, Vieira NM, Jazedje T, Muotri AR, Okamoto OK, Verjovski-Almeida S, Zatz M,. 2009. Gene expression profile of mesenchymal stem cells from paired umbilical cord units: Cord is different from blood. Stem Cell Rev 5: 387-401.
47. Secco M, Zucconi E, Vieira NM, Fogaca LL, Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR, Zatz M,. 2008. Multipotent stem cells from umbilical cord: Cord is richer than blood! Stem Cells 26: 146-150.
48. Subramanian A, Fong C-Y, Biswas A, Bongso A,. 2015. Comparative characterization of cells from the various compartments of the human umbilical cord shows that the Wharton's jelly compartment provides the best source of clinically utilizable mesenchymal stem cells. PLoS ONE 10 (6): e0127992
49. Troyer DL, Weiss ML,. 2008. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26: 591-599.
50. Wetzig A, Alaiya A, Al-Alwan M, Pradez CB, Pulicat MS, Al-Mazrou A, Shinwari Z, Sleiman GM, Ghebeh H, Al-Humaidan H, Gaafar A, Kanaan I, Adra C,. 2013. Differential marker expression by cultures rich in mesenchymal stem cells. BMC Cell Biol 14: 54.
51. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM,. 2003. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121: 368-374.
52. Wu KH, Chan CK, Tsai C, Chang YH, Sieber M, Chiu TH, Ho M, Peng CT, Wu HP, Huang JL,. 2011. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 91: 1412-1416.
53. Yang HT, Chao KC,. 2013. Foetal defence against cancer: A hypothesis. J Cell Mol Med 17: 1096-1098.
54. Yarmush ML, Toner M, Dunn JC, Rotem A, Hubel A, Tompkins RG,. 1992. Hepatic tissue engineering. Development of critical technologies. Ann N Y Acad Sci 665: 238-252.
55. Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, Chen L, Lv S, Li Y, Yu S, Geng H, Jin L, Lau GK, Wang FS,. 2012a. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 27: 112-120.
56. Zhang H, Zhang B, Tao Y, Cheng M, Hu J, Xu M, Chen H,. 2012b. Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach. Cell Biochem Funct 30: 643-649.